Literature DB >> 4169963

Papain digestion fragments of human IgM globulins.

C Mihaesco, M Seligmann.   

Abstract

Papain digestion of two Waldenström IgM globulins produced a high amount of small peptides and resulted in the formation of two end products, the Fabmicro and Fcmicro fragments. The Fcmicro fragment is characterized by a fast electrophoretic mobility, a high content in carbohydrate, and a high molecular weight. It was demonstrated that this fragment is made of heavy chain pieces belonging to several disulfide-linked monomeric subunits, presumably representing the carboxy-terminal end of the micro-chains. Fc fragments from the two macroglobulins could not be distinguished immunologically. An appreciable proportion of IgM molecules apparently underwent degradation without the formation of a stable Fc fragment. An Fc-like fragment, analogous to the reduced Fc fragment, was obtained at early stages of papain digestion of the IgM subunits. The Fabmicro fragment, with slow and individually distinct electrophoretic mobility, bears many physicochemical and immunological similarities to the Fabgamma fragment. It consists of one light chain and one Fd piece, both of which were isolated. The interaction of these two constituents was demonstrated by gel diffusion studies. Fab fragments of both IgM globulins were resolved into two subpopulations with different electric charges. In addition to these fragments, intermediary split products were observed at early stages of the degradation process, together with a high yield of small peptides mainly derived from the papain-sensitive region of the heavy chains. Immunologic data strongly suggested that this segment of micro-chains is situated between the Fd piece and the portion included in the Fc fragment. Several experiments indicated the importance of conformational antigenic specificity in both Fab and Fc regions of the IgM globulins.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4169963      PMCID: PMC2138466          DOI: 10.1084/jem.127.3.431

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

2.  A new supporting medium for preparative electrophoresis.

Authors:  H J MULLER-EBERHARD
Journal:  Scand J Clin Lab Invest       Date:  1960       Impact factor: 1.713

3.  [Study of the degradation of human serum albumin by rabbit spleen extract. II. Demonstration of three different specific groupings in the antigenic pattern of human albumin and of three corresponding antibodies in rabbit antihuman-albumin serum].

Authors:  C LEPRESLE
Journal:  Ann Inst Pasteur (Paris)       Date:  1955-12

4.  Analysis of hexose phosphates and sugar mixtures with the anthrone reagent.

Authors:  L C MOKRASCH
Journal:  J Biol Chem       Date:  1954-05       Impact factor: 5.157

5.  Method for the determination of hexosamines in tissues.

Authors:  N F BOAS
Journal:  J Biol Chem       Date:  1953-10       Impact factor: 5.157

6.  Zone electrophoresis in a starch supporting medium.

Authors:  H G KUNKEL; R J SLATER
Journal:  Proc Soc Exp Biol Med       Date:  1952-05

7.  The detection of monoclonal macroglobulinemia with antisera specific for gamma-M-globulins.

Authors:  L Korngold
Journal:  Int Arch Allergy Appl Immunol       Date:  1967

8.  Characterization of a human macroglobulin. II. Distribution of the disulfide bonds.

Authors:  F Miller; H Metzger
Journal:  J Biol Chem       Date:  1965-12       Impact factor: 5.157

9.  Carboxy-terminal amino acids of gamma-A and gamma-M heavy chains.

Authors:  C A Abel; H M Grey
Journal:  Science       Date:  1967-06-23       Impact factor: 47.728

10.  Macroglobulinemia. III. The effect of mercaptoethanol on the antigenic structure of macroglobulins.

Authors:  L KORNGOLD; G VAN LEEUWEN
Journal:  J Exp Med       Date:  1959-07-01       Impact factor: 14.307

View more
  12 in total

1.  A monoclonal macroglobulin with antinuclear activity.

Authors:  L Intrator; C Andre; C Chenal; C Sultan
Journal:  J Clin Pathol       Date:  1979-05       Impact factor: 3.411

2.  Lambda-gamma determinant of human IgG.

Authors:  R P Stokes; R A Thompson
Journal:  Experientia       Date:  1973-05-01

3.  Study of proteolytic removal of Fab delta and Fe delta determinants of lymphocyte membrane IgD using a direct rosette assay.

Authors:  J E Calvert; N R Ling; R Jefferis
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

4.  Proteolysis of rabbit immunoglobulin M by papain.

Authors:  B M McIlroy; G T Stevenson
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

5.  Observations on the reactions between D-positive red cells and ( 125 I)IgM anti-D molecules and subunits.

Authors:  A M Holburn; J P Cartron; J Economidou; B Gardner; N C Hughes-Jones
Journal:  Immunology       Date:  1971-09       Impact factor: 7.397

6.  Waldenström's macroglobulinaemia with anti-IgG activity: a series of five cases.

Authors:  L Bonomo; F Dammacco; A Tursi; D Trizio
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

7.  Immunoglobulin M: pentameric Fcmu fragments released by trypsin at higher temperatures.

Authors:  A G Plaut; T B Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  1970-02       Impact factor: 11.205

8.  Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor.

Authors:  M Gouault-Heilmann; M D Dumont; L Intrator; C Chenal; J L Lejonc
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

9.  The importance of quaternary structure in the expression of the C1-binding site of IgM.

Authors:  M O Bubb; J D Conradie
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

10.  Cryoprecipitation of an anti-Pr2 monoclonal IgM cold agglutinin in the presence of GM3 ganglioside.

Authors:  P Yeni; M L Harpin; B Habibi; A Billecocq; M J Morelec; J P Clauvel; F Danon; N Baumann; J C Brouet
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.